CALA Quote, Trading Chart, Calithera Biosciences Inc.
home / stock / cala / cala quote
$2.70 Last:
0.37% Change Percent:
$2.69 Open:
$2.70 Previous Close:
$2.75 High:
$2.3838 Low:
1,473,660 Volume:
03/05/2021 04:55:21 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-05 | 2.69 | 2.7 | 2.75 | 2.3838 | 1,473,660 |
| 2021-03-04 | 2.81 | 2.69 | 2.84 | 2.6 | 1,780,697 |
| 2021-03-03 | 2.92 | 2.81 | 2.9318 | 2.8 | 905,222 |
| 2021-03-02 | 2.97 | 2.88 | 2.97 | 2.875 | 1,780,967 |
| 2021-03-01 | 2.96 | 2.9 | 3 | 2.8595 | 1,099,410 |
| 2021-02-26 | 2.95 | 2.92 | 3 | 2.8301 | 808,161 |
| 2021-02-25 | 3.01 | 2.91 | 3.01 | 2.85 | 1,017,319 |
| 2021-02-24 | 3.01 | 2.98 | 3.07 | 2.9389 | 835,942 |
| 2021-02-23 | 2.89 | 2.96 | 3.02 | 2.75 | 1,924,103 |
| 2021-02-22 | 3.1 | 2.99 | 3.13 | 2.95 | 1,393,484 |
| 2021-02-19 | 3.14 | 3.1 | 3.18 | 3.07 | 907,826 |
| 2021-02-18 | 3.24 | 3.13 | 3.24 | 3.1087 | 1,115,982 |
| 2021-02-17 | 3.28 | 3.26 | 3.335 | 3.16 | 1,534,802 |
| 2021-02-16 | 3.2 | 3.26 | 3.32 | 3.12 | 2,844,568 |
| 2021-02-15 | 3.15 | 3.11 | 3.18 | 3.08 | 844,530 |
| 2021-02-12 | 3.15 | 3.11 | 3.18 | 3.08 | 839,739 |
| 2021-02-11 | 3.2 | 3.11 | 3.24 | 3.06 | 1,268,464 |
| 2021-02-10 | 3.26 | 3.2 | 3.29 | 3.065 | 1,056,504 |
| 2021-02-09 | 3.3 | 3.22 | 3.31 | 3.1985 | 980,861 |
| 2021-02-08 | 3.19 | 3.29 | 3.29 | 3.15 | 1,232,060 |
Calithera Biosciences Inc. Company Name:
CALA Stock Symbol:
NASDAQ Market:
Calithera Biosciences Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
SOUTH SAN FRANCISCO, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announce...
-
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced...
-
SOUTH SAN FRANCISCO, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced...